 Kelly Sullivan
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 22 | 2026 | 525 | 3.650 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 534 | 2.020 |
Why?
| | Proteome | 6 | 2026 | 514 | 1.110 |
Why?
| | Interferons | 6 | 2026 | 186 | 0.940 |
Why?
| | Apoptosis | 14 | 2023 | 2440 | 0.870 |
Why?
| | Piperazines | 6 | 2023 | 375 | 0.860 |
Why?
| | Transcriptome | 8 | 2026 | 1038 | 0.810 |
Why?
| | Liposarcoma | 1 | 2023 | 31 | 0.770 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 67 | 0.730 |
Why?
| | Genes, p53 | 2 | 2012 | 67 | 0.710 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 29 | 0.660 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.650 |
Why?
| | Transcriptional Activation | 3 | 2022 | 372 | 0.650 |
Why?
| | Azetidines | 1 | 2020 | 45 | 0.650 |
Why?
| | Databases, Genetic | 1 | 2021 | 238 | 0.620 |
Why?
| | Nuclear Proteins | 6 | 2017 | 740 | 0.620 |
Why?
| | Metabolome | 3 | 2026 | 388 | 0.620 |
Why?
| | Liver | 2 | 2026 | 1896 | 0.590 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2009 | 28 | 0.580 |
Why?
| | Neoplasms | 8 | 2023 | 2906 | 0.570 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 321 | 0.540 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 81 | 0.530 |
Why?
| | Hypersensitivity | 1 | 2020 | 254 | 0.520 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 69 | 0.520 |
Why?
| | Imidazoles | 4 | 2023 | 247 | 0.500 |
Why?
| | Sulfonamides | 1 | 2020 | 583 | 0.490 |
Why?
| | Histones | 4 | 2009 | 666 | 0.480 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1443 | 0.470 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2214 | 0.450 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 207 | 0.450 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 981 | 0.450 |
Why?
| | Isoquinolines | 1 | 2015 | 43 | 0.450 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 5 | 0.440 |
Why?
| | Receptors, Interferon | 3 | 2026 | 60 | 0.430 |
Why?
| | Immunity, Innate | 2 | 2020 | 835 | 0.420 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1480 | 0.370 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 2 | 2009 | 10 | 0.370 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 630 | 0.360 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 0.360 |
Why?
| | RNA, Messenger | 3 | 2020 | 2803 | 0.350 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 611 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 76 | 0.350 |
Why?
| | Patient Selection | 1 | 2015 | 738 | 0.330 |
Why?
| | Fibroblasts | 1 | 2016 | 1025 | 0.320 |
Why?
| | Interferon-alpha | 3 | 2020 | 193 | 0.320 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1767 | 0.300 |
Why?
| | Mice | 15 | 2026 | 18329 | 0.300 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 177 | 0.290 |
Why?
| | Medulloblastoma | 2 | 2022 | 215 | 0.290 |
Why?
| | Humans | 45 | 2026 | 145474 | 0.290 |
Why?
| | Animals | 21 | 2026 | 38030 | 0.290 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 117 | 0.280 |
Why?
| | Membrane Proteins | 1 | 2015 | 1164 | 0.270 |
Why?
| | Trisomy | 2 | 2019 | 78 | 0.270 |
Why?
| | Hypoxia | 2 | 2026 | 1199 | 0.260 |
Why?
| | Signal Transduction | 7 | 2024 | 5216 | 0.250 |
Why?
| | Drosophila Proteins | 1 | 2009 | 213 | 0.250 |
Why?
| | HCT116 Cells | 3 | 2017 | 76 | 0.250 |
Why?
| | Pyrimidines | 2 | 2024 | 530 | 0.250 |
Why?
| | Biomarkers | 3 | 2022 | 4295 | 0.240 |
Why?
| | Candidiasis, Oral | 1 | 2026 | 19 | 0.240 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.240 |
Why?
| | Platelet Activation | 1 | 2026 | 99 | 0.230 |
Why?
| | Human Development | 1 | 2025 | 20 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 28 | 0.210 |
Why?
| | Interferon-gamma | 2 | 2026 | 784 | 0.210 |
Why?
| | Bile Acids and Salts | 1 | 2026 | 163 | 0.210 |
Why?
| | Datasets as Topic | 2 | 2022 | 118 | 0.210 |
Why?
| | Erythropoiesis | 1 | 2024 | 57 | 0.210 |
Why?
| | Cell Proliferation | 7 | 2023 | 2507 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 624 | 0.200 |
Why?
| | Autophagy | 2 | 2018 | 291 | 0.200 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4560 | 0.200 |
Why?
| | Heme | 1 | 2024 | 89 | 0.200 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 22 | 0.200 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 41 | 0.200 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.190 |
Why?
| | Piperidines | 1 | 2024 | 222 | 0.190 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.190 |
Why?
| | Female | 18 | 2026 | 78844 | 0.190 |
Why?
| | Centrosome | 2 | 2023 | 71 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 440 | 0.180 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 155 | 0.180 |
Why?
| | Purines | 2 | 2020 | 187 | 0.180 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3542 | 0.180 |
Why?
| | Blood | 1 | 2022 | 107 | 0.170 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 200 | 0.170 |
Why?
| | Male | 13 | 2026 | 72842 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.170 |
Why?
| | Cilia | 2 | 2023 | 173 | 0.170 |
Why?
| | Cell Death | 1 | 2022 | 382 | 0.170 |
Why?
| | Autoimmunity | 3 | 2024 | 933 | 0.160 |
Why?
| | Seroconversion | 1 | 2021 | 48 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 113 | 0.160 |
Why?
| | Cytokines | 4 | 2024 | 2067 | 0.160 |
Why?
| | RNA Interference | 2 | 2015 | 475 | 0.160 |
Why?
| | Cell Line | 5 | 2021 | 2823 | 0.160 |
Why?
| | RNA Helicases | 1 | 2020 | 27 | 0.160 |
Why?
| | Pyrazoles | 2 | 2022 | 517 | 0.160 |
Why?
| | Sex Characteristics | 1 | 2025 | 782 | 0.150 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 193 | 0.150 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1454 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2022 | 3623 | 0.150 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2883 | 0.140 |
Why?
| | Protein Domains | 2 | 2017 | 311 | 0.140 |
Why?
| | Heart Defects, Congenital | 2 | 2026 | 910 | 0.140 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.140 |
Why?
| | DNA Repair | 1 | 2021 | 254 | 0.140 |
Why?
| | Metabolomics | 2 | 2021 | 732 | 0.140 |
Why?
| | Young Adult | 5 | 2025 | 14218 | 0.140 |
Why?
| | Complement System Proteins | 2 | 2021 | 314 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 18 | 0.140 |
Why?
| | Proteomics | 2 | 2023 | 1188 | 0.130 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 53 | 0.130 |
Why?
| | RNA Precursors | 2 | 2009 | 154 | 0.130 |
Why?
| | Cell Cycle | 2 | 2012 | 598 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 418 | 0.130 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 50 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 187 | 0.130 |
Why?
| | Adult | 9 | 2026 | 40777 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 4 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 452 | 0.130 |
Why?
| | Caspases | 2 | 2015 | 233 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 97 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | Antigens | 1 | 2018 | 348 | 0.120 |
Why?
| | Down-Regulation | 2 | 2017 | 618 | 0.120 |
Why?
| | Child, Preschool | 5 | 2025 | 11853 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 191 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 447 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 172 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.110 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 257 | 0.110 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5983 | 0.110 |
Why?
| | Genomics | 1 | 2021 | 825 | 0.110 |
Why?
| | Child | 7 | 2026 | 22707 | 0.110 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 11 | 0.110 |
Why?
| | Pyrones | 1 | 2015 | 11 | 0.110 |
Why?
| | Caspase 8 | 1 | 2015 | 47 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 53 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2018 | 4148 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1957 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 105 | 0.100 |
Why?
| | Transcription Factors | 2 | 2022 | 1734 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2017 | 429 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2018 | 728 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 387 | 0.100 |
Why?
| | Morpholines | 1 | 2015 | 130 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 139 | 0.100 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.100 |
Why?
| | Fluorouracil | 1 | 2015 | 231 | 0.100 |
Why?
| | Base Sequence | 3 | 2020 | 2170 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 239 | 0.100 |
Why?
| | Monocytes | 1 | 2016 | 539 | 0.100 |
Why?
| | Naphthalenes | 1 | 2013 | 54 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 641 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 762 | 0.100 |
Why?
| | Ligands | 1 | 2015 | 665 | 0.090 |
Why?
| | Genes, Synthetic | 1 | 2012 | 13 | 0.090 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.090 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 855 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 637 | 0.090 |
Why?
| | Infant | 3 | 2025 | 10077 | 0.090 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 218 | 0.090 |
Why?
| | Adolescent | 5 | 2025 | 22529 | 0.090 |
Why?
| | Autoantigens | 2 | 2023 | 427 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1808 | 0.090 |
Why?
| | Telomerase | 1 | 2013 | 246 | 0.080 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 326 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2129 | 0.080 |
Why?
| | Phenotype | 3 | 2026 | 3155 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2597 | 0.080 |
Why?
| | Hematopoiesis | 2 | 2021 | 193 | 0.080 |
Why?
| | Lipids | 1 | 2015 | 707 | 0.080 |
Why?
| | Cleavage Stimulation Factor | 1 | 2009 | 4 | 0.070 |
Why?
| | Endonucleases | 1 | 2008 | 34 | 0.070 |
Why?
| | Exoribonucleases | 1 | 2008 | 43 | 0.070 |
Why?
| | Mutation | 3 | 2015 | 4075 | 0.070 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2008 | 90 | 0.070 |
Why?
| | Middle Aged | 4 | 2025 | 36215 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1996 | 0.070 |
Why?
| | Mitochondria | 1 | 2015 | 992 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 333 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 172 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 237 | 0.060 |
Why?
| | Candida albicans | 1 | 2026 | 61 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 588 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2382 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2664 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2026 | 344 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2026 | 209 | 0.050 |
Why?
| | HeLa Cells | 3 | 2013 | 632 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 66 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 220 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 100 | 0.050 |
Why?
| | Proline | 1 | 2023 | 82 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 32 | 0.050 |
Why?
| | Blood Platelets | 1 | 2026 | 379 | 0.050 |
Why?
| | Centrioles | 1 | 2023 | 47 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 89 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.040 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 73 | 0.040 |
Why?
| | Protein Binding | 2 | 2020 | 2238 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 27 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2024 | 443 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 1310 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 171 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 47 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 266 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 22 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 167 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 149 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 202 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 33 | 0.030 |
Why?
| | Phosphorylation | 1 | 2022 | 1707 | 0.030 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 76 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 25 | 0.030 |
Why?
| | Hexokinase | 1 | 2017 | 18 | 0.030 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 15 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 399 | 0.030 |
Why?
| | Cell Lineage | 1 | 2019 | 377 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2017 | 51 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 553 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2017 | 133 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2019 | 226 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1509 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 17 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 642 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 441 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1023 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 376 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2017 | 247 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 41 | 0.030 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 122 | 0.030 |
Why?
| | Gene Editing | 1 | 2017 | 89 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 409 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 886 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 72 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1661 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1162 | 0.030 |
Why?
| | Glycolysis | 1 | 2017 | 340 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1132 | 0.030 |
Why?
| | Cohort Studies | 1 | 2026 | 6013 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 18 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 61 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 41 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 959 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1764 | 0.020 |
Why?
| | Serine Proteases | 1 | 2013 | 26 | 0.020 |
Why?
| | Protein Conformation | 1 | 2016 | 938 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 919 | 0.020 |
Why?
| | Protein Transport | 1 | 2014 | 442 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 961 | 0.020 |
Why?
| | Lung | 1 | 2026 | 4106 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 382 | 0.020 |
Why?
| | Obesity | 1 | 2026 | 3116 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 553 | 0.020 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 119 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 2046 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 934 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1321 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2460 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1100 | 0.020 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2008 | 2 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2008 | 25 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2008 | 15 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2008 | 92 | 0.020 |
Why?
| | Nucleotides | 1 | 2008 | 129 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 387 | 0.020 |
Why?
| | RNA | 1 | 2014 | 910 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 177 | 0.020 |
Why?
| | RNA Stability | 1 | 2008 | 107 | 0.020 |
Why?
| | Drosophila | 1 | 2008 | 164 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2006 | 335 | 0.010 |
Why?
| | Genotype | 1 | 2006 | 1852 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1435 | 0.010 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|